blog | Blossomhill Therapeutics

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, 2026, Blossomhill Therapeutics

BlossomHill Therapeutics (BLSM) Targets $125 Million IPO to Advance Precision Oncology Pipeline Built on Next-Generation Small Molecule Design

Eric Friedman

Aug 3, 2026, 4:00:36 PM

San Diego-based BlossomHill Therapeutics has filed for a Nasdaq IPO seeking to raise approximately $...

Subscribe to our Newsletter

Email

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.